We are live on ! Find out more
BI

Boulegeris Investments Portfolio holdings

AUM $200M
1-Year Est. Return 7%
This Fund
S&P 500
This Quarter Est. Return
-6.77%
1 Year Est. Return
+7%
3 Year Est. Return
+39.11%
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
-$8.64M
Cap. Flow
+$3.16M
Cap. Flow %
2.42%
Top 10 Hldgs %
62.74%
Holding
46
New
2
Increased
29
Reduced
14
Closed

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.6M
2
PPG icon
PPG Industries
PPG
+$2.68M
3
SWKS icon
Skyworks Solutions
SWKS
+$981K
4
MA icon
Mastercard
MA
+$351K
5
NVS icon
Novartis
NVS
+$319K

Sector Composition

Rank Sector Weight
1 Healthcare 26.36%
2 Real Estate 26.3%
3 Consumer Staples 8.37%
4 Technology 6.81%
5 Financials 5.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSBG
26
DELISTED
Lake Sunapee Bank Group
LSBG
$1.37M 1.05%
94,004
-296
-0.3% -$4.36K
SIR
27
DELISTED
SELECT INCOME REIT
SIR
$1.1M 0.84%
132,007
+25,594
+24% +$222K
DHC
28
Diversified Healthcare Trust
DHC
$2.13B
$1.05M 0.81%
65,680
+8,745
+15% +$144K
EOG icon
29
EOG Resources
EOG
$76.8B
$920K 0.7%
12,635
+75
+0.6% +$5.83K
OPK icon
30
Opko Health
OPK
$963M
$894K 0.68%
106,285
+26,120
+33% +$346K
MRO
31
DELISTED
Marathon Oil Corporation
MRO
$893K 0.68%
58,008
+11,145
+24% +$212K
IYW icon
32
iShares US Technology ETF
IYW
$25.1B
$680K 0.52%
27,508
-2,404
-8% -$62.1K
HSIC icon
33
Henry Schein
HSIC
$10.2B
$636K 0.49%
12,215
+4,042
+49% +$224K
MRTX
34
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$628K 0.48%
18,240
+825
+5% +$24.9K
BMRN icon
35
BioMarin Pharmaceuticals
BMRN
$11.7B
$575K 0.44%
5,460
+940
+21% +$126K
META icon
36
Meta Platforms (Facebook)
META
$1.5T
$544K 0.42%
6,055
+1,705
+39% +$156K
IHE icon
37
iShares US Pharmaceuticals ETF
IHE
$1.62B
$396K 0.3%
8,031
+1,650
+26% +$94.6K
AEM icon
38
Agnico Eagle Mines
AEM
$77.1B
$330K 0.25%
13,020
+1,320
+11% +$32.1K
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.11T
$307K 0.23%
2,355
-1,500
-39% -$206K
MMM icon
40
3M
MMM
$93B
$296K 0.23%
2,500
+610
+32% +$75K
SWKS icon
41
Skyworks Solutions
SWKS
$9.97B
$276K 0.21%
3,283
-10,728
-77% -$981K
REGN icon
42
Regeneron Pharmaceuticals
REGN
$78B
$265K 0.2%
+570
New +$306K
BCR
43
DELISTED
CR Bard Inc.
BCR
$217K 0.17%
+1,165
New +$221K
IYY icon
44
iShares Dow Jones US ETF
IYY
$3.05B
$215K 0.16%
4,450
-236
-5% -$12.1K
VTI icon
45
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
$197K 0.15%
1,673
-2,212
-57% -$232K
BRK.A icon
46
Berkshire Hathaway Class A
BRK.A
$1.11T
$195K 0.15%
1

Similar funds

Boulegeris Investments's Q3 2015 Portfolio in Review

As of Q3 2015, Boulegeris Investments held 46 positions worth $131M, down 6.2% from $139M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Trading was light in Q3 2015: portfolio turnover was 4.3%. Boulegeris Investments opened 2 new positions and made no exits, leaving the 46-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Real Estate and Consumer Staples.

  • Boulegeris Investments's largest Q3 2015 buy was Regeneron Pharmaceuticals: 570 shares worth $265K.
  • Boulegeris Investments added most to Monmouth Real Estate Investment Corp in Q3 2015, an estimated $3.32M increase.
  • Boulegeris Investments's biggest Q3 2015 reduction was Apple, cutting an estimated $3.6M.
  • Boulegeris Investments's ten largest holdings make up 63% of its $131M portfolio in Q3 2015.
  • Boulegeris Investments opened 2 new positions and closed 0 in Q3 2015.
  • Boulegeris Investments's portfolio value fell 6.2% quarter-over-quarter to $131M.

Based on Boulegeris Investments's 13F filing for Q3 2015, filed 27 Oct 2015.